The Development of Effective Therapy Targeting the Microenvironment of Cancer (2nd Edition)
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Tumor Microenvironment".
Deadline for manuscript submissions: 30 September 2026 | Viewed by 2956
Special Issue Editors
Interests: cancer treatment; experimental pathology; regenerative medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue is a continuation of our previous one, entitled "The Development of Effective Therapy Targeting the Microenvironment of Cancer”.
For many years, cancer medications have primarily targeted the inhibition of cancer cell growth. However, over the past 20 years, the mechanisms that form the tumor microenvironment through interactions with the stromal cells surrounding cancer cells have been elucidated. These cancer stromal cells are involved in the proliferation, invasion, and metastasis of cancer cells, even though they are normal cells. Therefore, therapeutic approaches targeting the tumor microenvironment have recently attracted much attention. In this Special Issue, we are seeking papers on innovative therapies targeting the tumor microenvironment. Proposals for any type of therapy, e.g., chemotherapy, antibody therapy, radiation therapy, etc., will be accepted. However, it is preferable that the results be proven to be effective at the animal level, rather than in a culture system.
Prof. Dr. Moriaki Kusakabe
Dr. Kanae Taruno
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- tumor microenvironment
- cancer therapy
- cancer cell
- animal level
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
